RxDoctor Payments Data

Pedro Dago, MD

Psychiatry · Chicago, ILNPI 1689637639

Payments from drug & device makers

$6,425in general payments, 2019–2025

Across 330 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$808
  • Neurocrine Biosciences, Inc.$536
  • Johnson & Johnson$481
  • Otsuka America Pharmaceutical, Inc.$437
  • Supernus Pharmaceuticals, Inc.$415
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$6,425100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,425 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$49,799
Medicare patients
87
Services billed
381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LybalviOlanzapine/Samidorphan Malate25$43,164
CaplytaLumateperone Tosylate11$17,767
TrintellixVortioxetine Hydrobromide28$17,317
AuvelityDextromethorphan Hbr/Bupropion15$16,924
Lurasidone Hcl21$7,689
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine112$4,400
Doxepin Hcl17$2,494
Aripiprazole49$2,204
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,532
Clonazepam209$1,455
Venlafaxine Hcl ErVenlafaxine Hcl74$1,154
Atomoxetine Hcl14$1,145
Quetiapine Fumarate49$1,038
Lithium Carbonate89$978
Trazodone Hcl63$890

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi$390$43,16425 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$808$17,76711 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$195$17,31728 claims
Axsome Therapeutics, Inc.Auvelity$365$16,92415 claims
Almatica Pharma LLCSertraline Hcl$44$16439 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →